This study evaluates the effectiveness of universal newborn screening for Sickle Cell Disease (SCD) in the Murcia region between 2016 and 2023. SCD is a hereditary blood disorder caused by hemoglobin S, which distorts red blood cells and leads to vaso-occlusive crises, organ damage, severe infections, and increased childhood mortality. Early diagnosis is essential, as preventive measures -such as penicillin prophylaxis and parental education- significantly improve the prognosis.
The study covered more than 100,000 newborns screened via Capillary Electrophoresis using heel-prick blood samples. The majority of the 500 cases detected and confirmed by genetic testing involved carriers, specifically of Hb S or Hb C. The prevalence of Sickle Cell Anemia (Hb SS) and Hb SC disease was estimated at approximatively 1 per 10,000 births.
The program also offered genetic counseling, although language and socioeconomic barriers sometimes limited participation. The authors conclude that universal screening enables early treatment, specialized follow-up, and improved prevention, thereby justifying its continued implementation in regions experiencing increased migration flows.
Test associated with this resource
Related instrument
コンパクトかつ導入しやすい全自動キャピラリー電気泳動システム
進化が違いを生む
Sebiaの専門知識を結集した高スループット装置。
Discover more resources on Hemoglobin Disorders
電気泳動装置で実施されるSebia検査のための包括的なデータ解析・判読支援ソフトウェア。
このセクションには広く一般に公開されることを目的とした情報が含まれており、そのため、お住まいの国では入手できない、または有効でない製品の詳細や情報が含まれている可能性があります。お近くのSebia担当者にお問い合わせください。医療従事者向けの情報です。試薬の添付文書および機器の取扱説明書の指示を注意深くお読みください。